Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price traded up 7.3% on Thursday . The company traded as high as $354.53 and last traded at $349.17. 5,559,052 shares were traded during mid-day trading, an increase of 0% from the average session volume of 5,544,094 shares. The stock had previously closed at $325.33.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Citigroup lowered shares of Astera Labs from a "buy" rating to a "market perform" rating in a research report on Tuesday. Loop Capital assumed coverage on shares of Astera Labs in a research report on Thursday, March 5th. They issued a "buy" rating and a $250.00 price objective on the stock. Needham & Company LLC increased their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a "buy" rating in a research report on Wednesday, May 6th. Royal Bank Of Canada increased their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an "outperform" rating in a research report on Wednesday, May 6th. Finally, TD Cowen increased their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the stock a "hold" rating in a research report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $233.75.
Check Out Our Latest Stock Report on ALAB
Astera Labs Price Performance
The firm has a market capitalization of $59.85 billion, a PE ratio of 235.93, a price-to-earnings-growth ratio of 4.22 and a beta of 3.35. The stock's 50-day moving average price is $182.05 and its 200 day moving average price is $162.57.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company's quarterly revenue was up 93.5% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.
Insider Transactions at Astera Labs
In other news, COO Sanjay Gajendra sold 400,000 shares of the firm's stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company's stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the firm's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 2,316,257 shares of company stock valued at $474,860,636. 12.50% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Astera Labs
Several institutional investors have recently bought and sold shares of ALAB. Atreides Management LP increased its holdings in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. Vanguard Group Inc. increased its holdings in Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock valued at $2,690,907,000 after buying an additional 1,693,918 shares during the period. Amundi increased its holdings in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company's stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Rafferty Asset Management LLC purchased a new position in Astera Labs during the third quarter valued at approximately $209,599,000. Finally, BNP Paribas Financial Markets increased its holdings in Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company's stock valued at $220,733,000 after buying an additional 960,899 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.
About Astera Labs
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report